Neurotrophin-Induced Migration and Neuronal Differentiation of Multipotent Astrocytic Stem Cells In Vitro

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Douglas Escobar, Martha ^a   Rossignol, Candace ^a   Steindler, Dennis ^a,b   Zheng, Tong ^a,b   Weiss, Michael D ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN REGION; CELL MIGRATION; CELL TYPE; CHEMOKINESIS; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; MOUSE; MULTIPOTENT ASTROCYTIC STEM CELL; MULTIPOTENT STEM CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEWBORN; NONHUMAN; TISSUE DISTRIBUTION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CATTLE; CELL DIFFERENTIATION; CELL MIGRATION ASSAYS; CELL MOVEMENT; HUMANS; MICE; MULTIPOTENT STEM CELLS; NERVE GROWTH FACTORS; NEURONS; RATS; TUBULIN;

RATTUS;

EID: 84871250576     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051706     Document Type: Article

References (64)

1. Beilharz EJ, Klempt ND, Klempt M, Sirimanne E, Dragunow M, et al. (1993) Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res 18: 209-215.
2. Lawn J, Shibuya K, Stein C, (2005) No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths. Bull World Health Organ 83: 409-417.
3. Shankaran S, (2002) The postnatal management of the asphyxiated term infant. Clin Perinatol 29: 675-692.
4. Pierrat V, Haouari N, Liska A, Thomas D, Subtil D, et al. (2005) Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study. Arch Dis Child Fetal Neonatal Ed 90: F257-261.
5. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, et al. (2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353: 1574-1584.
6. Wolfberg AJ, Dammann O, Gressens P, (2007) Anti-inflammatory and immunomodulatory strategies to protect the perinatal brain. Semin Fetal Neonatal Med 12: 296-302.
7. Low JA, Ludwin SK, Fisher S, (1996) Severe fetal asphyxia associated with neuropathology. Am J Obstet Gynecol 175: 1383-1385.
8. Thornberg E, Thiringer K, Odeback A, Milsom I, (1995) Birth asphyxia: incidence, clinical course and outcome in a Swedish population. Acta Paediatr 84: 927-932.
9. Levene MI, Gibson NA, Fenton AC, Papathoma E, Barnett D, (1990) The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol 32: 567-574.
10. Crowther CA, Hiller JE, Doyle LW, Haslam RR, (2003) Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290: 2669-2676.
11. Mittendorf R, Dammann O, Lee KS, (2006) Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor. J Perinatol 26: 57-63.
12. Bakshi A, Shimizu S, Keck CA, Cho S, LeBold DG, et al. (2006) Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur J Neurosci 23: 2119-2134.
13. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, et al. (2005) Moderate hypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neurol 32: 18-24.
14. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, et al. (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365: 663-670.
15. Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P (2007) Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev: CD003311.
16. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, et al. (2009) Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124: e218-226.
17. Daadi MM, (2008) In vitro assays for neural stem cell differentiation: induction of dopaminergic phenotype. Methods Mol Biol 438: 205-212.
18. Romanko MJ, Rothstein RP, Levison SW, (2004) Neural stem cells in the subventricular zone are resilient to hypoxia/ischemia whereas progenitors are vulnerable. J Cereb Blood Flow Metab 24: 814-825.
19. Levison SW, Rothstein RP, Romanko MJ, Snyder MJ, Meyers RL, et al. (2001) Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci 23: 234-247.
20. Ness JK, Romanko MJ, Rothstein RP, Wood TL, Levison SW, (2001) Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 23: 203-208.
21. Zheng T, Rossignol C, Leibovici A, Anderson KJ, Steindler DA, et al. (2006) Transplantation of multipotent astrocytic stem cells into a rat model of neonatal hypoxic-ischemic encephalopathy. Brain Res 1112: 99-105.
22. Bibel M, Barde YA, (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14: 2919-2937.
23. Teng YD, Yu D, Ropper AE, Li J, Kabatas S, et al. (2011) Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research. Curr Neuropharmacol 9: 574-585.
24. Sizonenko SV, Bednarek N, Gressens P, (2007) Growth factors and plasticity. Semin Fetal Neonatal Med 12: 241-249.
25. Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, et al. (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2: e689.
26. Dawbarn D, Allen SJ, (2003) Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29: 211-230.
27. Binder DK, Scharfman HE, (2004) Brain-derived neurotrophic factor. Growth Factors 22: 123-131.
28. Laywell ED, Rakic P, Kukekov VG, Holland EC, Steindler DA, (2000) Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A 97: 13883-13888.
29. Belmadani A, Tran PB, Ren D, Miller RJ, (2006) Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 26: 3182-3191.
30. Rosenblum S, Wang N, Smith TN, Pendharkar AV, Chua JY, et al. (2012) Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke 43: 1624-1631.
31. Chen B, Gao XQ, Yang CX, Tan SK, Sun ZL, et al. (2009) Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 1284: 1-11.
32. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S, (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 70: 271-288.
33. Kameda M, Shingo T, Takahashi K, Muraoka K, Kurozumi K, et al. (2007) Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci 26: 1462-1478.
34. Cornejo M, Nambi D, Walheim C, Somerville M, Walker J, et al. (2010) Effect of NRG1, GDNF, EGF and NGF in the migration of a Schwann cell precursor line. Neurochem Res 35: 1643-1651.
35. Pozas E, Ibanez CF, (2005) GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons. Neuron 45: 701-713.
36. Borghesani PR, Peyrin JM, Klein R, Rubin J, Carter AR, et al. (2002) BDNF stimulates migration of cerebellar granule cells. Development 129: 1435-1442.
37. Bejot Y, Mossiat C, Giroud M, Prigent-Tessier A, Marie C, (2011) Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. PLoS One 6: e29405.
38. Glaser T, Brose C, Franceschini I, Hamann K, Smorodchenko A, et al. (2007) Neural cell adhesion molecule polysialylation enhances the sensitivity of embryonic stem cell-derived neural precursors to migration guidance cues. Stem Cells 25: 3016-3025.
39. Athanasios F, Afrodite N, Effstratios P, Demetrios K, (2012) Co-expression of bone morphogenetic protein 6 with estrogen receptor a in endometriosis. Arch Gynecol Obstet 285: 1001-1007.
40. Zhang L, Tan X, Dong C, Zou L, Zhao H, et al. (2012) In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Wharton's jelly, into choline acetyltransferase (ChAT)-positive cells. Int J Dev Neurosci.
41. Liu Y, Wang L, Long Z, Zeng L, Wu Y, (2012) Protoplasmic astrocytes enhance the ability of neural stem cells to differentiate into neurons in vitro. PLoS One 7: e38243.
42. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745.
43. Petridis AK, El Maarouf A, (2011) Brain-derived neurotrophic factor levels influence the balance of migration and differentiation of subventricular zone cells, but not guidance to the olfactory bulb. J Clin Neurosci 18: 265-270.
44. Kamei N, Tanaka N, Oishi Y, Hamasaki T, Nakanishi K, et al. (2007) BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures. Spine (Phila Pa 1976) 32: 1272-1278.
45. Fraichard A, Chassande O, Bilbaut G, Dehay C, Savatier P, et al. (1995) In vitro differentiation of embryonic stem cells into glial cells and functional neurons. J Cell Sci 108 (Pt 10): 3181-3188.
46. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, et al. (2006) Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 199: 179-190.
47. Li X, Yang Z, Zhang A, (2009) The effect of neurotrophin-3/chitosan carriers on the proliferation and differentiation of neural stem cells. Biomaterials 30: 4978-4985.
48. Yang Z, Duan H, Mo L, Qiao H, Li X, (2010) The effect of the dosage of NT-3/chitosan carriers on the proliferation and differentiation of neural stem cells. Biomaterials 31: 4846-4854.
49. Blits B, Kitay BM, Farahvar A, Caperton CV, Dietrich WD, et al. (2005) Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 23: 313-324.
50. Castellanos DA, Tsoulfas P, Frydel BR, Gajavelli S, Bes JC, et al. (2002) TrkC overexpression enhances survival and migration of neural stem cell transplants in the rat spinal cord. Cell Transplant 11: 297-307.
51. Ferriero DM, (2004) Neonatal brain injury. N Engl J Med 351: 1985-1995.
52. Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F,et al. Cell Therapy for Neonatal Hypoxia-Ischemia and Cerebral Palsy. Annals of Neurology: Pre-print.
53. Barrett RD, Bennet L, Davidson J, Dean JM, George S, et al. (2007) Destruction and reconstruction: hypoxia and the developing brain. Birth Defects Res C Embryo Today 81: 163-176.
54. Stone BS, Zhang J, Mack DW, Mori S, Martin LJ, et al. (2008) Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol 64: 535-546.
55. Llado J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD, (2004) Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 27: 322-331.
56. Daadi MM, Davis AS, Arac A, Li Z, Maag AL,et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 41: 516-523.
57. Ma J, Wang Y, Yang J, Yang M, Chang KA, et al. (2007) Treatment of hypoxic-ischemic encephalopathy in mouse by transplantation of embryonic stem cell-derived cells. Neurochem Int 51: 57-65.
58. Sato Y, Nakanishi K, Hayakawa M, Kakizawa H, Saito A, et al. (2008) Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem/progenitor cells together with chondroitinase ABC. Reprod Sci 15: 613-620.
59. Pineda JR, Rubio N, Akerud P, Urban N, Badimon L, et al. (2007) Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells. Gene Ther 14: 118-128.
60. Paratcha G, Ibanez CF, Ledda F, (2006) GDNF is a chemoattractant factor for neuronal precursor cells in the rostral migratory stream. Mol Cell Neurosci 31: 505-514.
61. Shi H, Patschan D, Dietz GP, Bahr M, Plotkin M, et al. (2008) Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol Renal Physiol 294: F229-235.
62. Park KI, Ourednik J, Ourednik V, Taylor RM, Aboody KS, et al. (2002) Global gene and cell replacement strategies via stem cells. Gene Ther 9: 613-624.
63. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, et al. (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101: 18117-18122.
64. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, et al. (2006) Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 26: 125-134.